Det nye forumet finner du her

Tilbake til: Farma og medisin
Innlegg av: Frontmasta (10.01.18 19:47 ), lest 1345 ganger
Ticker: NANO
Endret: 10.01.18 23:03

RE^1: NANO. Endringssøknaden som ble avslått.......

Se her...............

According to the company conference call held October 15, 2015, Nordic will be looking in to expand the previous dosing portion of the pivotal study PARADIGME and incorporating it into the ongoing Phase 1/2 (Lymrit 37-01) study.


https://lymphomanewstoday.com/2015/10/19/nordic-nanovector-revises-clinical-development-strategy-for-follicular-non-hodgkins-lymphoma-treatment-betalutin/